The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Impact of Medication Therapy Discontinuation on Mortality After Myocardial Infarction
Abstract
BACKGROUND: Nonadherence to medications is common, but the determinants and consequences are poorly defined. The objectives of this study were to identify patient and myocardial infarction (MI) treatment factors associated with medication therapy discontinuation and to assess the impact of medication discontinuation 1 month after MI on 12-month mortality. METHODS: This was a multicenter prospective cohort of patients with MI enrolled in the Prospective Registry Evaluating Myocardial Infarction: Event and Recovery study. The outcomes were use of aspirin, beta-blockers, and statins at 1 month after MI hospitalization among patients discharged with all 3 medications as well as 12-month mortality. RESULTS: Of 1521 patients discharged with all 3 medications, 184 discontinued use of all 3 medications, 56 discontinued use of 2 medications, 272 discontinued use of 1 medication, and 1009 continued taking all 3 medications at 1 month. In multivariable analyses, patients not graduating from high school (odds ratio [OR], 1.76; 95% confidence interval [CI], 1.20-2.60) were more likely to discontinue use of all medications. The effect of increasing age on medication therapy discontinuation was greater for females (OR, 1.77; 95% CI, 1.34-2.34) than males (OR, 1.23; 95% CI, 1.02-1.47). Patients who discontinued use of all medications at 1 month had lower 1-year survival (88.5% vs 97.7%; log-rank P<.001) compared with patients who continued to take 1 or more medication(s). In multivariable survival analysis, medication therapy discontinuation was independently associated with higher mortality (hazards ratio, 3.81; 95% CI, 1.88-7.72). Results were consistent when evaluating discontinuation of use of aspirin, beta-blockers, and statins separately. CONCLUSIONS: Medication therapy discontinuation after MI is common and occurs early after discharge. Patients who discontinue taking evidence-based medications are at increased mortality risk. These findings suggest the need to improve the transition of care from the hospital to outpatient setting to ensure that patients continue to take medications that have mortality benefit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
Self-citationAdherence to Long-Term Therapies: Evidence for Action
De Geest, S., & Sabaté, E. (2003) · European Journal of Cardiovascular Nursing · doi:10.1016/s1474-5151(03)00091-4 · Cited by 6,272
Braunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D., Kupersmith, J., Levin, T. N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.10.1193 · Cited by 4,487
Committee Members, Braunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D., Kupersmith, J., et al. (2002) · Circulation · doi:10.1161/01.cir.0000037106.76139.53 · Cited by 845
Ryan, T. J., Antman, E. M., Brooks, N. H., Califf, R. M., Hillis, L. D., Hiratzka, L. F., Rapaport, E., Riegel, B., Russell, R. O., Smith, E. E., et al. (1999) · Circulation · doi:10.1161/01.cir.100.9.1016 · Cited by 743
Cannon, C. P., Battler, A., Brindis, R. G., Cox, J. L., Ellis, S. G., Every, N. R., Flaherty, J. T., Harrington, R. A., Krumholz, H. M., Simoons, M. L., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01702-8 · Cited by 671
Self-citationRogers, W. J., Canto, J. G., Lambrew, C. T., Tiefenbrunn, A. J., Kinkaid, B., Shoultz, D. A., Frederick, P. D., & Every, N. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00996-7 · Cited by 657
Can simple clinical measurements detect patient noncompliance?
Haynes, R. B., Taylor, D. W., Sackett, D. L., Gibson, E. S., Bernholz, C. D., & Mukherjee, J. (1980) · Hypertension · doi:10.1161/01.hyp.2.6.757 · Cited by 514
Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease
Newby, L. K., Allen LaPointe, N. M., Chen, A. Y., Kramer, J. M., Hammill, B. G., DeLong, E. R., Muhlbaier, L. H., & Califf, R. M. (2006) · Circulation · doi:10.1161/circulationaha.105.505636 · Cited by 505
Marciniak, T. A., Ellerbeck, E. F., Radford, M. J., Kresowik, T. F., Gold, J. A., Krumholz, H. M., Kiefe, C. I., Allman, R. M., Vogel, R. A., & Jencks, S. F. (1998) · JAMA · doi:10.1001/jama.279.17.1351 · Cited by 496
Self-citation
Cited by
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R., Carnethon, M., De Simone, G., Ferguson, T. B., Flegal, K., Ford, E., Furie, K., Go, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.191259 · Cited by 3,908
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R., Carnethon, M., De Simone, G., Ferguson, T. B., Flegal, K., Ford, E., Furie, K., Go, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.191261 · Cited by 3,140
Medication Adherence: WHO Cares?
Brown, M. T., & Bussell, J. K. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0575 · Cited by 1,928
“Nonadherence to lipid-lowering and antiplatelet therapies is associated with an increased risk of adverse cardiovascular outcomes.(16,32,34,36-41) Aside from the increased risk of MI, stroke, and death, stent recipients who prematurely discontinue clopidogrel also have an increased rate of stent thrombosis.”
BackgroundAuthors/Task Force Members, Bassand, J.-P., Hamm, C. W., Ardissino, D., Boersma, E., Budaj, A., Fernandez-Aviles, F., Fox, K. A. A., Hasdai, D., Ohman, E. M., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm161 · Cited by 1,849
Medication Adherence: Its Importance in Cardiovascular Outcomes
Ho, P. M., Bryson, C. L., & Rumsfeld, J. S. (2009) · Circulation · doi:10.1161/circulationaha.108.768986 · Cited by 1,488
Self-citationRasmussen, J. N., Chong, A., & Alter, D. A. (2007) · JAMA · doi:10.1001/jama.297.2.177 · Cited by 975
Whooley, M. A. (2008) · JAMA · doi:10.1001/jama.2008.711 · Cited by 887
Rapezzi, C., Biagini, E., & Branzi, A. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm498 · Cited by 595
White, H. D., & Chew, D. P. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61237-4 · Cited by 588
Primary Medication Non-Adherence: Analysis of 195,930 Electronic Prescriptions
Fischer, M. A., Stedman, M. R., Lii, J., Vogeli, C., Shrank, W. H., Brookhart, M. A., & Weissman, J. S. (2010) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1253-9 · Cited by 572
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2015) · Kardiologia Polska · doi:10.5603/kp.2015.0243 · Cited by 458
Giannuzzi, P. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.20.2194 · Cited by 411
Gehi, A. K. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.16.1798 · Cited by 339
Predictors of Nonadherence to Statins: A Systematic Review and Meta-Analysis
Mann, D. M., Woodward, M., Muntner, P., Falzon, L., & Kronish, I. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1p150 · Cited by 329
Aggregate National Experience With the Wearable Cardioverter-Defibrillator
Chung, M. K., Szymkiewicz, S. J., Shao, M., Zishiri, E., Niebauer, M. J., Lindsay, B. D., & Tchou, P. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.04.016 · Cited by 297
Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review
De Vera, M. A., Bhole, V., Burns, L. C., & Lacaille, D. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12339 · Cited by 289
Impact of Medication Nonadherence on Hospitalizations and Mortality in Heart Failure
Fitzgerald, A. A., Powers, J. D., Ho, P. M., Maddox, T. M., Peterson, P. N., Allen, L. A., Masoudi, F. A., Magid, D. J., & Havranek, E. P. (2011) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2011.04.011 · Cited by 284
Self-citationHo, P. M., Lambert-Kerzner, A., Carey, E. P., Fahdi, I. E., Bryson, C. L., Melnyk, S. D., Bosworth, H. B., Radcliff, T., Davis, R., Mun, H., et al. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12944 · Cited by 282
Self-citationGender and racial disparities in adherence to statin therapy: A meta-analysis
Lewey, J., Shrank, W. H., Bowry, A. D. K., Kilabuk, E., Brennan, T. A., & Choudhry, N. K. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.02.011 · Cited by 267
“Nonadherent diabetic patients experience rates of all-cause mortality that are 80% higher than their adherent counterparts.(10,11) Nonadherence is associated with a substantial economic cost.”
BackgroundBitton, A., Choudhry, N. K., Matlin, O. S., Swanton, K., & Shrank, W. H. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.09.004 · Cited by 256
Depression and Cardiovascular Disorders
Whooley, M. A., & Wong, J. M. (2013) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050212-185526 · Cited by 241
“1980), diabetes mellitus (Ho et al. 2006a), HF (Granger et al. 2005), and MI (Ho et al. 2006b).”
BackgroundOgedegbe, G. O. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.1307 · Cited by 230
Kronish (2011) · doi:10.1161/circulationaha.110.983874 · Cited by 182
Discontinuation of Statin Therapy and Clinical Outcome After Ischemic Stroke
Colivicchi, F., Bassi, A., Santini, M., & Caltagirone, C. (2007) · Stroke · doi:10.1161/strokeaha.107.487017 · Cited by 174
Medication adherence: emerging use of technology
Granger, B. B., & Bosworth, H. B. (2011) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e328347c150 · Cited by 165
Rethinking adherence: a health literacy—informed model of medication self-management
Bailey, S. C., Oramasionwu, C. U., & Wolf, M. S. (2013) · Journal of Health Communication · doi:10.1080/10810730.2013.825672 · Cited by 160
P4P4P: An Agenda For Research On Pay-For-Performance For Patients
Volpp, K. G., Pauly, M. V., Loewenstein, G., & Bangsberg, D. (2009) · Health Affairs · doi:10.1377/hlthaff.28.1.206 · Cited by 136
Khonsari, S., Subramanian, P., Chinna, K., Latif, L. A., Ling, L. W., & Gholami, O. (2015) · European Journal of Cardiovascular Nursing · doi:10.1177/1474515114521910 · Cited by 127
Ofori-Asenso, R., Jakhu, A., Zomer, E., Curtis, A. J., Korhonen, M. J., Nelson, M., Gambhir, M., Tonkin, A., Liew, D., & Zoungas, S. (2018) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glx169 · Cited by 118
The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction
Bramlage, P., Messer, C., Bitterlich, N., Pohlmann, C., Cuneo, A., Stammwitz, E., Tebbenjohanns, J., Gohlke, H., Senges, J., & Tebbe, U. (2010) · Heart · doi:10.1136/hrt.2009.188607 · Cited by 115
“The effect size in the Canadian registry pointed into the same direction with on average greater reduction in mortality in SAMI.”
BackgroundInfluentialFrishman, W. H. (2007) · Cardiology in Review · doi:10.1097/crd.0b013e3180cabbe7 · Cited by 101
Crawshaw, J., Auyeung, V., Norton, S., & Weinman, J. (2016) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2016.09.003 · Cited by 97
Unmet Needs in LDL-C Lowering: When Statins Won’t Do!
Krähenbühl, S., Pavik-Mezzour, I., & von Eckardstein, A. (2016) · Drugs · doi:10.1007/s40265-016-0613-0 · Cited by 89
Quality Improvement: Science and Action
Ting, H. H., Shojania, K. G., Montori, V. M., & Bradley, E. H. (2009) · Circulation · doi:10.1161/circulationaha.108.768895 · Cited by 68
De Vera, M. A., Choi, H., Abrahamowicz, M., Kopec, J., Goycochea-Robles, M. V., & Lacaille, D. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.142455 · Cited by 64
The role of psychological science in efforts to improve cardiovascular medication adherence.
Bosworth, H. B., Blalock, D. V., Hoyle, R. H., Czajkowski, S. M., & Voils, C. I. (2018) · American Psychologist · doi:10.1037/amp0000316 · Cited by 35
Bell, D. S. H., Dharmalingam, M., Kumar, S., & Sawakhande, R. B. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01408.x · Cited by 28
(2018) · Europe PMC (PubMed Central) · Cited by 10
Metadata
- Authors
- Ho, P. M., Spertus, J. A., Masoudi, F. A., Reid, K. J., Peterson, E. D., Magid, D. J., Krumholz, H. M., & Rumsfeld, J. S.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2006-09-25
- Volume
- 166
- Issue
- 17
- Pages
- 1842
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W1968837758
- Cited by
- 633
- References
- 26
- FWCI
- 21.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.